Inhibition of master transcription factors in pluripotent cells induces early stage differentiation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 5, 2014, Pages 1778-1783

  De, Debojyoti ^a   Jeong, Myong Ho ^a   Leem, Young Eun ^a   Svergun, Dmitri I ^b   Wemmer, David E ^c   Kang, Jong Sun ^a   Kim, Kyeong Kyu ^a   Kim, Sung Hou ^c  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; OCTAMER TRANSCRIPTION FACTOR 4; S PHASE KINASE ASSOCIATED PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTOME;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL TYPE; CONTROLLED STUDY; GENETIC TRANSDUCTION; HEART MUSCLE CELL; MOUSE; NEURAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REPRODUCIBILITY; TRANSACTIVATION; TRANSCRIPTION REGULATION; X RAY CRYSTALLOGRAPHY;

ANIMALS; CELL DIFFERENTIATION; ESCHERICHIA COLI PROTEINS; MICE; MODELS, BIOLOGICAL; MODELS, MOLECULAR; PLURIPOTENT STEM CELLS; SCATTERING, SMALL ANGLE; SOLUTIONS; SOXB1 TRANSCRIPTION FACTORS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC; X-RAY DIFFRACTION;

EID: 84893441053     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1323386111     Document Type: Article

References (35)

1. Keller G (2005) Embryonic stem cell differentiation: Emergence of a new era in biology and medicine. Genes Dev 19(10):1129-1155.
2. Riazi AM, Kwon SY, Stanford WL, 2009, Stem cell sources for regenerative medicine. Methods Mol Biol 482:55-90.
3. Emborg ME, et al. (2013) Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain. Cell Rep 3(3):646-650.
4. Xu T, Zhang M, Laurent T, Xie M, Ding S (2013) Concise review: Chemical approaches for modulating lineage-specific stem cells and progenitors. Stem Cells Transl Med 2(5): 355-361.
5. Giudice A, Trounson A (2008) Genetic modification of human embryonic stem cells for derivation of target cells. Cell Stem Cell 2(5):422-433.
6. Chambers I, Tomlinson SR (2009) The transcriptional foundation of pluripotency. Development 136(14):2311-2322.
7. Kashyap V, et al. (2009) Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev 18(7):1093-1108.
8. Sharov AA, et al. (2008) Identification of Pou5f1, Sox2, and Nanog downstream target genes with statistical confidence by applying a novel algorithm to time course microarray and genome-wide chromatin immunoprecipitation data. BMC Genomics 9:269.
9. Nowling TK, Johnson LR, Wiebe MS, Rizzino A (2000) Identification of the transactivation domain of the transcription factor Sox-2 and an associated co-activator. J Biol Chem 275(6):3810-3818.
10. Pan GJ, Pei DQ (2003) Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog. Cell Res 13(6):499-502.
11. Lim HY, et al. (2009) Implication of human OCT4 transactivation domains for selfregulatory transcription. Biochem Biophys Res Commun 385(2):148-153.
12. Macarthur BD, Ma'ayan A, Lemischka IR (2009) Systems biology of stem cell fate and cellular reprogramming. Nat Rev Mol Cell Biol 10(10):672-681.
13. Niwa H, Miyazaki J, Smith AG (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24(4):372-376.
14. Wang Z, Oron E, Nelson B, Razis S, Ivanova N (2012) Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells. Cell Stem Cell 10(4): 440-454.
15. Verma SK, et al. (2009) Antibodies against refolded recombinant envelope protein (domain III) of Japanese encephalitis virus inhibit the JEV infection to Porcine Stable Kidney cells. Protein Pept Lett 16(11):1334-1341.
16. Guevara Patiño JA, Holder AA, McBride JS, Blackman MJ (1997) Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. J Exp Med 186(10):1689-1699.
17. Ha SC, Pereira JH, Jeong JH, Huh JH, Kim SH (2009) Purification of human transcription factors Nanog and Sox2, each in complex with Skp, an Escherichia coli periplasmic chaperone. Protein Expr Purif 67(2):164-168.
18. Korndörfer IP, Dommel MK, Skerra A (2004) Structure of the periplasmic chaperone Skp suggests functional similarity with cytosolic chaperones despite differing architecture. Nat Struct Mol Biol 11(10):1015-1020.
19. Petoukhov MV, et al. (2012) New developments in the ATSAS program package for small-angle scattering data analysis. J Appl Cryst 45:342-350.
20. Walton TA, Sousa MC (2004) Crystal structure of Skp, a prefoldin-like chaperone that protects soluble and membrane proteins from aggregation. Mol Cell 15(3):367-374.
21. Petoukhov MV, Svergun DI (2005) Global rigid body modeling of macromolecular complexes against small-angle scattering data. Biophys J 89(2):1237-1250.
22. Reményi A, et al. (2003) Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers. Genes Dev 17(16): 2048-2059.
23. Kohn JE, et al. (2004) Random-coil behavior and the dimensions of chemically unfolded proteins. Proc Natl Acad Sci USA 101(34):12491-12496.
24. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF (1999) In vivo protein transduction: Delivery of a biologically active protein into the mouse. Science 285(5433):1569-1572.
25. Chambers I, Smith A (2004) Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene 23(43):7150-7160.
26. van der Heyden MA, Defize LH (2003) Twenty one years of P19 cells: What an embryonal carcinoma cell line taught us about cardiomyocyte differentiation. Cardiovasc Res 58(2):292-302.
27. Moretti A, et al. (2006) Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127(6):1151-1165.
28. Zahir T, et al. (2009) Neural stem/progenitor cells differentiate in vitro to neurons by the combined action of dibutyryl cAMP and interferon-gamma. Stem Cells Dev 18(10): 1423-1432.
29. Mummery CL, et al. (2012) Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview. Circ Res 111(3): 344-358.
30. Sachinidis A, et al. (2003) Cardiac specific differentiation of mouse embryonic stem cells. Cardiovasc Res 58(2):278-291.
31. Gump JM, Dowdy SF (2007) TAT transduction: The molecular mechanism and therapeutic prospects. Trends Mol Med 13(10):443-448.
32. Hay DC, Sutherland L, Clark J, Burdon T (2004) Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells. Stem Cells 22(2):225-235.
33. Kishi M, et al. (2000) Requirement of Sox2-mediated signaling for differentiation of early Xenopus neuroectoderm. Development 127(4):791-800.
34. Ferri AL, et al. (2004) Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain. Development 131(15):3805-3819.
35. Blanchet CE, et al. (2012) Instrumental setup for high-throughput small-and wideangle solution scattering at the X33 beamline of EMBL Hamburg. J Appl Cryst 45: 489-495.